Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seidman

Showing results (311-320 of 386) with videos related to

Pageof 39
Sort By:
Neurochemistry International|November 30, 2004
Role of Bcl-2 family of proteins in mediating apoptotic death of PC12 cells exposed to oxygen and glucose deprivationDavid Koubi, Hao Jiang, Lijie Zhang, et al.
The American Journal of Surgical Pathology|August 2, 2007
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinomaAnais Malpica, Michael T Deavers, Carmen Tornos, et al.
Hearing Research|December 1, 1993
Substance P increases cochlear blood flow without changing cochlear electrophysiology in ratsG M McLaren, W S Quirk, E Laurikainen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancerMonica N Fornier, Andrew D Seidman, Diana Lake, et al.
Human Pathology|August 7, 2004
Borderline ovarian tumors: key points and workshop summarySteven G Silverberg, Debra A Bell, Robert J Kurman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancerA D Seidman, H I Scher, J L Gabrilove, et al.
NPJ Breast Cancer|October 29, 2024
Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumabS M Chew, E Ferraro, Y Chen, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary reportB S Reichman, A D Seidman, J P Crown, et al.
The Laryngoscope|December 21, 2007
Direct electrical stimulation of Heschl's gyrus for tinnitus treatmentMichael D Seidman, Dirk De Ridder, Kost Elisevich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancerB S Reichman, A D Seidman, J P Crown, et al.
Pageof 39

Showing results (311-320 of 386) with videos related to

Sort By:
Pageof 39
Neurochemistry International|November 30, 2004
Role of Bcl-2 family of proteins in mediating apoptotic death of PC12 cells exposed to oxygen and glucose deprivationDavid Koubi, Hao Jiang, Lijie Zhang, et al.
The American Journal of Surgical Pathology|August 2, 2007
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinomaAnais Malpica, Michael T Deavers, Carmen Tornos, et al.
Hearing Research|December 1, 1993
Substance P increases cochlear blood flow without changing cochlear electrophysiology in ratsG M McLaren, W S Quirk, E Laurikainen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancerMonica N Fornier, Andrew D Seidman, Diana Lake, et al.
Human Pathology|August 7, 2004
Borderline ovarian tumors: key points and workshop summarySteven G Silverberg, Debra A Bell, Robert J Kurman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancerA D Seidman, H I Scher, J L Gabrilove, et al.
NPJ Breast Cancer|October 29, 2024
Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumabS M Chew, E Ferraro, Y Chen, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary reportB S Reichman, A D Seidman, J P Crown, et al.
The Laryngoscope|December 21, 2007
Direct electrical stimulation of Heschl's gyrus for tinnitus treatmentMichael D Seidman, Dirk De Ridder, Kost Elisevich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancerB S Reichman, A D Seidman, J P Crown, et al.
Pageof 39